Cresset Asset Management LLC Sells 90,266 Shares of Relx Plc (NYSE:RELX)

Cresset Asset Management LLC lowered its position in shares of Relx Plc (NYSE:RELX - Free Report) by 82.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,123 shares of the technology company's stock after selling 90,266 shares during the period. Cresset Asset Management LLC's holdings in Relx were worth $869,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in RELX. Franklin Resources Inc. boosted its position in Relx by 3.3% during the 3rd quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company's stock valued at $873,000 after buying an additional 588 shares during the period. Kathmere Capital Management LLC boosted its position in Relx by 7.2% during the 4th quarter. Kathmere Capital Management LLC now owns 48,141 shares of the technology company's stock valued at $2,187,000 after buying an additional 3,228 shares during the period. Park Avenue Securities LLC boosted its position in Relx by 48.3% during the 4th quarter. Park Avenue Securities LLC now owns 61,173 shares of the technology company's stock valued at $2,778,000 after buying an additional 19,912 shares during the period. Heritage Family Offices LLP boosted its position in Relx by 15.8% during the 4th quarter. Heritage Family Offices LLP now owns 24,632 shares of the technology company's stock valued at $1,119,000 after buying an additional 3,366 shares during the period. Finally, Ritholtz Wealth Management boosted its position in Relx by 0.5% during the 4th quarter. Ritholtz Wealth Management now owns 148,234 shares of the technology company's stock valued at $6,733,000 after buying an additional 781 shares during the period. Hedge funds and other institutional investors own 15.02% of the company's stock.

Relx Trading Up 0.9%

Shares of NYSE:RELX traded up $0.49 on Friday, hitting $54.53. The company had a trading volume of 432,311 shares, compared to its average volume of 707,376. The firm's 50-day simple moving average is $51.14 and its two-hundred day simple moving average is $48.92. Relx Plc has a 1 year low of $43.28 and a 1 year high of $55.21. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The firm has a market capitalization of $100.66 billion, a price-to-earnings ratio of 29.32, a P/E/G ratio of 2.73 and a beta of 0.86.

Relx Increases Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be paid a $0.5586 dividend. This represents a dividend yield of 1.6%. This is a positive change from Relx's previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. Relx's dividend payout ratio (DPR) is presently 59.68%.

Analysts Set New Price Targets

Several brokerages have weighed in on RELX. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Finally, The Goldman Sachs Group started coverage on shares of Relx in a research report on Wednesday, March 26th. They issued a "buy" rating for the company. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Relx presently has a consensus rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.